Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP” Jul 23, 2021
PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Jul 21, 2021
